Remove 2024 Remove Contract research organization Remove Ecosystems
article thumbnail

Are You Leveraging the Drug Discovery and Early Development Outsourcing Services Ecosystem to Accelerate Growth?

Frost & Sullivan

growth from 2023 to 2024. What is driving transformation in the pharma industry? Growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) leading industry growth. Total R&D expenditure is approximately $276.81